RC
ELV icon

Randolph Company’s Elevance Health ELV Stock Holding History

Randolph Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-35,390
Closed -$9.99M – 42
2019
Q2 		$9.99M Buy
+35,390
New +$9.67M 1.72% 29
2017
Q1 		– Sell
-62,250
Closed -$8.95M – 40
2016
Q4 		$8.95M Sell
62,250
-65
-0.1% -$8.7K 1.83% 21
2016
Q3 		$7.81M Buy
+62,315
New +$8.05M 1.97% 19

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $52.8B AUM 12.71% 1-Year Est. Return

Randolph Company's ELV Position: Q3 2019 in Review

Randolph Company sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 35,390 shares — an estimated $9.99M sold.

Randolph Company first reported a position in ELV in Q3 2016 and held it in 3 quarters. The position peaked at $9.99M in Q2 2019. 1,016 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Randolph Company reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
  • Randolph Company sold 35,390 Elevance Health shares in Q3 2019, an estimated $9.99M.
  • Randolph Company first reported a position in Elevance Health in Q3 2016 and held it in 3 quarters.
  • Randolph Company's Elevance Health position peaked at $9.99M in Q2 2019.
  • 1,016 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Randolph Company's 13F filing for Q3 2019, filed 16 Oct 2019.